DeutschNewstral
Reata Pharmaceuticals Inc.
Biogen to bulk up rare disease treatments with $7 billion Reata acquisitionseattletimes.com
Reata Pharmaceuticals will move HQ into new Plano high-riseDallas News- Reata, Dycom rise; Novavax, Ambarella fallseattletimes.com
- Reata stock soars on FDA approval for ultra-rare disease drug after 15 yearsDallas News
- Peloton hopes to peddle its empty Plano office spaceDallas News
Progressive, Iovance fall; Target, Take-Two risedailyherald.com- IHere’s why Reata Pharmaceuticals gained 20% on Wednesdayinvezz.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.